References
[1] Wang Z, Shi W. The influence of sequential therapy with azithromycin and low-dose methylprednisolone on the treatment effect of mycoplasma pneumonia in children. Heilongjiang Med J. 2022;35(6):1323-5.
[2] Sun M, Zhang Q. Analysis of clinical risk factors for severe mycoplasma pneumonia in children. Lingnan J Emerg Med. 2024;29(2):159-61.
[3] Weng Q, Zheng L. Adverse reactions and rationality of azithromycin in the treatment of mycoplasma pneumonia in children. Jilin Med J. 2024;45(4):892-5.
[4] Xu H, Shang L. Research progress in the diagnosis and treatment of mycoplasma pneumonia in children. Chin J Clin Res. 2010;13(29):146-8.
[5] Han Y. Study on the efficacy of standardized treatment with azithromycin combined with glucocorticoids for mycoplasma pneumonia in children. China Stand. 2024;(8):285-8.
[6] Lin Q, Zhou P, Zhai S, et al. Systematic review on the efficacy and safety of azithromycin for injection in the treatment of mycoplasma pneumonia in children. Chin J Pharm. 2018;29(22):3146-52.
[7] Zhou P, Liang S, Zhai S. Introduction to the implementation plan of the rapid advice guideline for the use of azithromycin for injection in pediatrics. Chin J Pharm. 2018;29(4):436-40.
[8] Maiilashabir. Analysis of the pharmacology and clinical application of azithromycin. Chin Med Eng. 2014;22(9):188.
[9] Mu A. The effect of methylprednisolone combined with azithromycin in the treatment of children with mycoplasma infection-induced lobar pneumonia. Chin J Health Care Med. 2024;36(9):92-4.
[10] Gao Z. Clinical effect and influence on inflammatory factor levels of heat-toxin-clearing injection combined with azithromycin in the treatment of mycoplasma pneumonia in children. Clin Ration Drug Use. 2023;16(1):114-7.
[11] Wang J, Wei H. Clinical effect of ambroxol hydrochloride combined with azithromycin in the treatment of mycoplasma pneumonia complicated with acute bronchitis in children. Clin Ration Drug Use. 2023;16(4):116-8.
[12] Wan J. Clinical research progress of azithromycin in the treatment of mycoplasma pneumonia in children. Heilongjiang Sci. 2022;13(10):85-7.
[13] Fu X. Literature analysis and countermeasures of adverse reactions of azithromycin for injection. Chin Prescr Drug. 2014;12(6):48-9.
[14] Tang Q, Yue W. One case of severe adverse reaction caused by azithromycin for injection. Chin Med Herald. 2008;(2):117.
[15] Mao Y, Wang J. A case of sudden cardiac death caused by azithromycin for injection. Chin J Mod Drug Appl. 2014;8(17):156.
[16] Liu C, Wang J, Huang Y, et al. Allergy test study of azithromycin for injection in guinea pigs in non-clinical safety evaluation research. Chin J Drug Adverse React. 2022;19(11):1161-4,1169.
[17] Xia L. Analysis of a case of severe adverse reaction caused by intravenous injection of azithromycin. Chin J Ethnomed Ethnopharm. 2010;19(23):187.
[18] Zhang Y, Jiang R, et al. A case of anaphylactic shock and vomiting caused by azithromycin for injection. Cent South Pharm J. 2018;16(6):879.
[19] Yan X, Yu P. A case of anaphylactic shock with abdominal pain as a precursor caused by azithromycin for injection. Chin J Mod Appl Pharm. 2003;20(1):25.
[20] Luo J, Li X. Analysis of risk factors for adverse reactions in children caused by azithromycin for injection. Strait Pharm J. 2019;31(2):286-7.
[21] He L, Yuan Y, et al. Correlation study between the course of azithromycin and drug concentration in children with mycoplasma pneumoniae pneumonia. Chin Med J. 2023;58(2):206-10.
[22] Zhang X. Population pharmacokinetic study of azithromycin by NONMEM method [dissertation]. Shenyang: Shenyang Pharmaceutical University; 2010.
[23] Liang W. Biopharmaceutics and Pharmacokinetics. 3rd ed. Beijing: People's Medical Publishing House; 2008. p. 321.
[24] Liang W. Biopharmaceutics and Pharmacokinetics. 3rd ed. Beijing: People's Medical Publishing House; 2008. p. 110.
[25] Gao Y, Shen J. Two cases of death caused by anaphylactic shock due to azithromycin. Chin J Hosp Pharm Eval Anal. 2016;16(1):13.